
June 23, 2023
RegMed Investors’ (RMi) pre-open: another pullback and the end to a losing week?
June 22, 2023
RegMed Investors’ (RMi) pre-open: who left the barn door open?
June 21, 2023
RegMed Investors (RMi) Research Note: Editas Medicine (EDIT) prices a $125 M offering of 12.5 M shares at $10.00
June 21, 2023
RegMed Investors (RMi) Research Note: UniQure NV (QURE -$8.08 or -41.72% to $11.33) crashed
June 21, 2023
RegMed Investors’ (RMi) pre-open: fluctuating, rotating or was it wavering
June 20, 2023
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector is back to the upside as market cools
June 20, 2023
RegMed Investors’ (RMi) pre-open: will Icarus’ sector fly or stick to the currents?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors